BRIEF published on 10/19/2026 at 07:50, 12 days 5 hours ago Poxel Announces Third Quarter 2026 Financial Results Poxel Financial Results TWYMEEG® Sales Increase Sumitomo Pharma Projections Royalty Adjustments Japanese Market Performance
BRIEF published on 10/19/2026 at 07:50, 12 days 5 hours ago Poxel's Financial Performance in the Third Quarter of 2026 Sales Growth Japan Royalties TWYMEEG® Poxel
BRIEF published on 10/19/2026 at 07:50, 12 days 5 hours ago Les Performances Financières de Poxel au Troisième Trimestre 2026 Croissance Des Ventes Japon TWYMEEG® Poxel Redevances
BRIEF published on 10/19/2026 at 07:50, 12 days 5 hours ago Poxel annonce ses résultats financiers du troisième trimestre 2026 Résultats Financiers De Poxel Les Ventes De TWYMEEG® Augmentent Prévisions De Sumitomo Pharma Ajustements Des Redevances Performance Du Marché Japonais
PRESS RELEASE published on 10/19/2026 at 07:45, 12 days 5 hours ago Information financière trimestrielle / Information financière du troisième trimestre Poxel annonce une croissance de 29% de son chiffre d’affaires pour le troisième trimestre 2026, principalement grâce aux ventes nettes consolidées de TWYMEEG® au Japon Chiffre D'affaires Croissance Japon Poxel TWYMEEG
PRESS RELEASE published on 10/19/2026 at 07:45, 12 days 5 hours ago Quarterly financial reporting / Third quarter financial report Poxel reports revenue growth in Q3 2026 with TWYMEEG® net sales in Japan surpassing JPY 2.9 billion, up 29% from Q3 2025. Positive net royalties expected for fiscal year 2026 Revenue Net Sales Poxel TWYMEEG Positive Royalties
BRIEF published on 09/03/2026 at 19:20, 1 month 27 days ago Change at the helm of Poxel: Laure-Hélène Mercier appointed President Shareholders Biotechnology Governance Appointment Poxel
BRIEF published on 09/03/2026 at 19:20, 1 month 27 days ago Laure-Hélène Mercier nommée Présidente du Conseil d'Administration de Poxel Biotechnologie Gouvernance D'Entreprise Nomination Au Conseil D'administration Poxel Surveillance Financière
BRIEF published on 09/03/2026 at 19:20, 1 month 27 days ago Changement à la tête de Poxel : Laure-Hélène Mercier nommée Présidente Gouvernance Actionnaires Biotechnologie Nomination Poxel
BRIEF published on 09/03/2026 at 19:20, 1 month 27 days ago Laure-Hélène Mercier Appointed Chair of Poxel's Board Biotechnology Corporate Governance Board Appointment Poxel Financial Oversight
Published on 10/30/2026 at 23:35, 13 hours 16 minutes ago Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 13 hours 21 minutes ago Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 20:47, 16 hours 4 minutes ago CoTec Holdings Corp. Comments on Share Trading
Published on 10/30/2026 at 19:00, 17 hours 51 minutes ago Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 21 hours 21 minutes ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 10/30/2026 at 22:49, 14 hours 2 minutes ago EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE
Published on 10/30/2026 at 18:38, 18 hours 13 minutes ago EQS-Adhoc: Starcom Holding AD publishes Interim Q3 2026 Financial Report
Published on 10/30/2026 at 23:00, 13 hours 51 minutes ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 23:00, 13 hours 51 minutes ago Biophytis publie les résultats du premier semestre 2026 et fait le point sur sa stratégie
